
News
Novo Nordisk AS's stock price in Copenhagen fell by 1.81%, closing at 308.80, with a cumulative decline of 31.70% this week, marking the company's worst weekly performance since its IPO in Denmark

Novo Nordisk AS's stock price in Copenhagen fell by 1.81%, closing at 308.80, with a cumulative decline of 31.70% this week, marking the company's worst weekly performance since its IPO in Denmark